"Stable Gastric Pentadecapeptide BPC 157 clinical applications." PubMed
Some preclinical data suggests BPC-157 demonstrates oral bioavailability, but direct comparisons between oral and injectable delivery in humans have not been established through published clinical trials
Mechanistically, kefiran (KE) and kefir exo-polysaccharides (KEPS), as well as KPs, inhibit key inflammatory signaling pathways including NF-B, p-MAPK, p-IkB, pp38, and p-JNK, thereby reducing epithelial cell activation, synovitis, macrophage-mediated inflammation, and cytokine overproduction in systemic and localized inflammatory conditions (Chuang et al., 2023
Batches are accompanied by specification documentation and Certificate of Analysis (COA) data where available
Avocados and asparagus support glutathione levels and fit within the Bulletproof diet
Rueda-Ruzafa et al